Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2017 16:05 ET | Source: Esperion Therapeutics, Inc.

Esperion Provides Bempedoic Acid Development Program Updates; Reports First Quarter 2017 Financial Results

ANN ARBOR, Mich., May 04, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary,...